Summary & Overview
CPT 00534: Anesthesia for Transvenous Cardioverter–Defibrillator Insertion
CPT code 00534 identifies anesthesia services for transvenous implant or replacement of a cardioverter–defibrillator (ICD) inserted via a central venous approach into the heart chambers. This code captures anesthesiologist or anesthesia team involvement when another clinician performs the device implantation. Nationally, ICD implantation is a high‑acuity cardiac procedure with implications for perioperative risk management, resource utilization, and bundled payment design.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines coverage and billing considerations that affect reimbursement for anesthesia services tied to ICD procedures under these payers.
Readers will find: a concise clinical context for the service; common associated procedures and settings; payer coverage considerations and typical billing modifiers; and benchmarking content to help health systems align coding practice with national payer expectations. The content focuses on operational and policy-relevant aspects of using CPT code 00534 for anesthesia claims in hospital or catheterization laboratory settings.
Billing Code Overview
CPT code 00534 describes anesthesia services provided for patients undergoing transvenous cardioverter–defibrillator (ICD) insertion or replacement performed by another provider. The procedure involves insertion of a pacing cardioverter–defibrillator device via a central vein (commonly the neck) into the cardiac chambers to treat life‑threatening arrhythmias; the surgical provider may be placing a new device or replacing an existing transvenous ICD.
Service type: Anesthesia for electrophysiology/implantable cardiac device procedures
Typical site of service: Hospital operating room or cardiac catheterization laboratory
Clinical & Coding Specifications
Clinical Context
A 68-year-old male with ischemic cardiomyopathy and recurrent symptomatic ventricular tachycardia is scheduled for insertion of a transvenous implantable cardioverter–defibrillator (ICD). Preoperative assessment documents diagnoses of I25.10 (atherosclerotic heart disease), prior valve disease with I34.0 (mitral insufficiency), and reduced ejection fraction consistent with I50.9 (heart failure). The electrophysiology team obtains vascular access via the right internal jugular vein and advances transvenous leads into the right atrium and right ventricle while a cardiovascular surgeon or electrophysiologist implants the pulse generator in a subcutaneous pocket. An anesthesia provider (often a physician with taxonomy 207L00000X or 207LA0401X) evaluates the patient preoperatively, administers monitored anesthesia care or general endotracheal anesthesia as indicated, manages hemodynamics intraoperatively, and provides postoperative recovery monitoring. Typical monitoring includes continuous ECG, invasive arterial pressure for unstable patients, central venous access if needed, and readiness for temporary pacing or advanced cardiac life support. The procedure typically occurs in a cardiac catheterization laboratory or hybrid operating room. Common clinical workflow steps: pre-op evaluation and optimization, intraoperative anesthesia management and hemodynamic support during transvenous lead placement and device testing, coordination with electrophysiology for intraoperative device interrogation and threshold testing, and post-anesthesia recovery with telemetry and pain management prior to discharge or transfer to a monitored inpatient bed.